Heart Test Laboratories Inc. (HSCS) Peer Comparison
$4.81
$0.18
(3.89%)
As on 25-Sep-2026 13:34EDT
Market cap
$25 Mln
Revenue (TTM)
$90 Mln
P/E Ratio
--
P/B Ratio
70.8
Div. Yield
0 %
Edit
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
25 | 99 | 118,666 | 44,113 | 42,703 |
Revenue ($ Mln) |
90 | 2 | 37,542 | 7,372 | 3,458 |
Net Profit ($ Mln) |
-10.26 | -6.96 | 5,230.00 | 1,440.00 | 1,014.77 |
Net Margin (%) |
-11.46 | -430.43 | 13.93 | 19.53 | 29.34 |
RoE (%) |
-- | -115.97 | 10.47 | 20.18 | 13.86 |
Price to Earnings |
-- | -- | 22.85 | 30.86 | 43.45 |
Price-To-Book |
70.85 | 18.49 | 2.36 | 5.99 | 5.77 |
Income Statement ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 2.04 | 36,364.00 | 6,948.00 | 3,195.31 |
|
Cost of Revenue
|
0.13 | 1.47 | 12,721.00 | 3,305.00 | 782.02 |
|
Gross Profit
|
-0.13 | 0.57 | 23,643.00 | 3,643.00 | 2,413.29 |
|
Operating Expenses
|
8.28 | 8.88 | 17,179.00 | 2,164.00 | 1,496.92 |
|
Operating Profit (EBIT)
|
-8.41 | -8.32 | 6,467.00 | 1,479.00 | 916.37 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-9.14 | -8.23 | 6,136.00 | 1,435.00 | 1,194.51 |
|
Provision for Tax
|
-3.68 | -- | 1,299.00 | 132.00 | 285.60 |
|
Profit after Tax (Net Income)
|
-9.14 | -8.23 | 4,800.00 | 1,303.00 | 908.91 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | 4,662.00 | 1,303.00 | -- |
Liabilities ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
225.53 | 6.68 | 49,463.00 | 6,741.00 | 7,214.75 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
175.50 | 0.08 | 31,298.00 | 3,639.00 | 127.54 |
|
Current Liabilities
|
4,861.11 | 0.78 | 11,658.00 | 2,347.00 | 1,637.06 |
|
Total Liabilities
|
5,262.67 | 7.55 | 93,028.00 | 12,727.00 | 8,979.34 |
Assets ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2,679.75 | 2.56 | 68,240.00 | 8,133.00 | 981.71 |
|
Current Assets
|
2,582.93 | 4.99 | 24,787.00 | 4,594.00 | 7,997.63 |
|
Total Assets
|
5,262.14 | 7.55 | 93,028.00 | 12,727.00 | 8,979.34 |
|
Total Debt*
|
3,936.65 | 0.25 | 27,961.00 | 3,354.00 | 95.86 |
|
Net Current Assets
|
-2.28 | 4.20 | 13,129.00 | 2,247.00 | 6,360.57 |
Cashflow ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-7.43 | -5.13 | 7,330.00 | 1,559.00 | 1,415.23 |
|
Cash Flow from Investing Activities
|
-0.04 | -0.01 | -2,934.00 | -394.00 | -1,104.36 |
|
Cash from Financing Activities
|
8.03 | 5.40 | -4,751.00 | -715.00 | -9.33 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-0.44 | -121.56 | 6.24 | 13.32 | 13.75 |
|
ROE (%)
|
-8.10 | -125.56 | 9.85 | 20.62 | 13.93 |
|
ROA (%)
|
-0.35 | -109.60 | 5.20 | 10.61 | 11.14 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-211,666.47 | -404.08 | 13.20 | 18.75 | 28.44 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.01 | -0.05 | 0.08 | 0.07 | 0.16 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-4.30 | 21.50 | 2.96 | 1.09 | 27.27 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -- |
|
Price / Book Value
|
-- | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-270.99 | 0.54 | 1.91 | 0.85 | -5.19 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
17.46 | 0.04 | 0.57 | 0.50 | 0.01 |
|
Short term debt to equity ratio
|
16.68 | 0.02 | 0.04 | 0.05 | 0.00 |
|
Current Ratio
|
0.53 | 6.36 | 2.13 | 1.96 | 4.89 |
|
Quick Ratio
|
0.40 | 6.21 | 1.62 | 1.52 | -- |
|
Interest Coverage
|
-21.72 | -364.19 | 9.58 | 13.81 | -- |
Operating Efficiency Ratios
| Heart Test Laboratories Inc. (HSCS) | Nutriband Inc (NTRB) | Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.00 | 5.81 | 18.27 | 21.40 | 41.01 |
|
Asset Turnover
|
0.00 | 0.27 | 0.39 | 0.57 | 0.39 |
|
Receivable days
|
183.94 | 17.24 | 66.08 | 73.89 | 135.31 |
|
Inventory Days
|
900,351.58 | 40.99 | 164.05 | 111.40 | -- |
|
Payable days
|
437,150.98 | 149.23 | 73.12 | 61.34 | 15.90 |
|
Cash Conversion Cycle
|
463,384.53 | -91.00 | 157.01 | 123.95 | -- |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
